Intra-Cellular Therapies
ITCI
#1825
Rank
NZ$15.51 B
Marketcap
$146.38
Share price
0.28%
Change (1 day)
49.02%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.71 Billion

According to Intra-Cellular Therapies's latest financial reports the company has NZ$1.71 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Intra-Cellular Therapies - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.78 B-15.54%
2022-12-31NZ$0.93 B54.44%
2021-12-31NZ$0.60 B-33.75%
2020-12-31NZ$0.91 B173.94%
2019-12-31NZ$0.33 B-35.8%
2018-12-31NZ$0.51 B-20.75%
2017-12-31NZ$0.65 B17.91%
2016-12-31NZ$0.55 B-20.14%
2015-12-31NZ$0.69 B319.61%
2014-12-31NZ$0.16 B266%
2013-12-31NZ$45.2 M94.25%
2013-03-31NZ$0 M
2012-12-31NZ$23.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$75.74 M-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.44 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.92 B-46.06%๐Ÿ‡บ๐Ÿ‡ธ USA